| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Trust and Productivity |
|
Digg It - Trust and Productivity
When two people trust each other, their relationship is productive. When two organisations have trusting relationships and interactions their relationship is productive. When trust is violated, relationships are unproductive and According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product organisations and individuals suffer. The definition of trust does not include any element of good or bad. Two criminals may trust each other. It does not have any element of right or wrong. Two people with diametrically opposin ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in views believing each is wrong may trust each other. Trust is a personal issue. It indicates a willingness to become vulnerable to another person or organisation based on positive expectations of their conduct. In their article lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. posted on beyondintractibility.org, Lewicki and Tomlinson describe two types of trust; Calculus-Based Trust (CBT) and Identification-Based Trust (IBT). The former is the style of trust which builds early in a relationship. CBT here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe s the trust calculated as a result of the impact of incentives to stay in or leave the relationship. IBT is the trust developed later in a relationship. IBT is the trust developed when individuals have a deeper understanding of d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro each other through repeated interactions. When Identification-based trust is developed, goals and values become shared. Meetings are required less frequently. Audits of processes become a shared and welcome responsibility. Devel ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ping and adhering to specifications becomes a less time consuming task. Differences in opinion created by low levels of understanding of corporate philosophy and culture are reduced substantially. Procurement practises in the be easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tter managed auto-manufacturers is an example of building trust and improving productivity. Calculus-based trust developed between manufacturers and suppliers as manufacturers shared their plans with suppliers and asked supplier nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically to open their books and accept a declared return on investment or percentage margin in return. Many suppliers were unwilling to open their books and take advantage of the planning certainty being offered. They did not trust the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ auto-manufacturer enough to open their books. Many auto-manufacturers were not willing to commit to their plans, placing the risk on the supplier and therefore losing the trust of the suppliers. The few manufacturers and suppl ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ers who got past this early calculus-based trust development were able to go further. Suppliers were invited by the auto-manufacturers to be directly involved in research and development, not only in car/parts design, but also in ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a manufacturing processes at the auto-manufacturer and the supplier. Those suppliers and auto-manufacturers that were able to move through the calculus-based trust on to the identification-based trust were able to increase produc dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ivity dramatically by sharing not only common goals but common values. The resultant integration of supplier's strategies and tactics into the auto-manufacturer's strategies and tactics brought increased productivity, lower cost cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s, improved flexibility and increased profits to those organisations that could establish the required level of trust. Trust, however, is not static. Trust is destroyed when the positive expectations of conduct which underpin th tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen willingness to open oneself to vulnerability are not forthcoming. In the early stages of building trust, small deviations from the expected positive conduct can destroy trust. In established identification-based trust, repeated t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel infringements or a severe break in delivery against expectation is required to destroy trust. Trust is personal. It is between two people. When organisations "trust" each other it is a result of trust between individuals in the ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust organisation. Hence, trust and its benefits in productivity are destroyed when the expectations of an individual in an organisation is not met by an individual in another organisation. When new individuals enter an established r y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products elationship is when the risk of destroying trust is the highest. Unfortunately, not many people recognise the benefits of trust and consequently, do not rate the impact of trust being destroyed as being high. Therefore, to maint . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de in the benefits of trust between organisations it is incumbent upon the individuals currently involved in the relationship to bring the new person into the fold, building their trust and their belief that trust has economic benef elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip its. Organisations that recognise the value of trust and actively discourage activities which would destroy trust, whilst actively encouraging activities and a culture which values trust, reap a significant competitive advantage tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Conflict at Work, Don't Take It Personally
|